L'institut Domaines de recherche Plates-formes techniques Venir à l'INM. Pourquoi? Actu / presse

U583

Equipe 1
Génétique et thérapie des cécités rétiniennes

Equipe 2
Physiopathologie et thérapies de l’oreille interne

Equipe 3
Neurobiologie cellulaire et moléculaire du système somato-sensoriel

Equipe 4
Physiologie et approches thérapeutiques des pathologies médullaires

Equipe 5
Physiologie et thérapie des désordres vestibulaires

U844

 

| Accueil | Contact | Légal |    

Research fields

Team 01:
Genetic and therapy of retinal blindness

Inherited retinal dystrophies and the visual cycle in the retinal pigment epithelium

 

Group Leader :
Philippe Brabet ( CR1 Inserm )
Tél : 04 99 63 60 52
Send a mail




Research Group :                                               Tel : +33 (0) 499 636 052                 Fax : +33 (0) 499 636 020

Philippe Brabet (CR1 INSERM)                                     Mail : brabet@montp.inserm.fr
Carl Arndt (PH)                                                                  Mail : carl.arndt@chu-montpellier.fr
Marie Pequignot (Post-doctoral fellow)                         Mail : pequignot@montp.inserm.fr
Thomas Guignard (Ph.D. student)                                  Mail : thomG@montp.inserm.fr
Karim Chekroud (Ph.D. student)                                    Mail : chekroud@montp.inserm.fr
Laurent Guillou (TR INSERM)                                       Mail : lguillou@montp.inserm.fr

Collaborators :

Marcel Mersel (DR2 INSERM, INM)                            Mail: mersel@univ-montp1.fr
Yvan Boublik  (IFR122, CNRS, CRBM)                      Mail: yvan.boublik@crbm.cnrs.fr
Andreas Stahl  (Palo Alto, CA, USA)                             Mail: astahl@stanford.edu
Claire Rogel-Gaillard  (UMR INRA CEA 314)            Mail : rogel@jouy.inra.fr

 

- Our objective
- Methodologies
- References
- Lab members

 

Our objective

Our main goal is to identify new genes regulating key steps of the visual cycle in the RPE cells, to get insights into the molecular mechanisms which contribute to the retinal dystrophies, and to propose therapeutic strategies to slow the progression of diseases involving the visual cycle.
Vitamin A and its derivatives (retinoids) are essential components in vision. In the retina of vertebrates, the Visual Cycle, which is an enzymatic pathway of retinoids derived from beta-carotene, is essential to light perception. Mutations of enzymes and binding proteins involved in this process lead to retinal degenerations and phenotypically heterogeneous forms of blindness named pigmentary retinopathies and macular dystrophies. Besides, visual cycle promotes lipofuscin accumulation in the RPE, a phototoxic deposit involved in several retinal dystrophies including Stargardt disease, Best macular dystrophy and possibly in age-related retinal degenerations.

 

In the rod and cone photoreceptors, G protein-coupled receptors called opsins combine with a chromophore 11-cis retinal to constitute the visual pigments that mediate photon absorption. This capture generates 11-cis to all-trans isomerization and leads to the removal of all-trans retinal. The visual cycle aims to restore the 11-cis retinal chromophore and so the sensitivity to light.
The retinal pigment epithelium (RPE) is a monolayer of cells adjacent to the photoreceptors that supports many physiological functions of the retina and notably most of the rod visual cycle steps. Key steps of the retinoid cycle are fulfilled by three major enzymes located to endoplasmic reticulum of the RPE. First, LRAT (lecithin retinol acyl transferase) adds a fatty acid to photo-generated all-trans retinol forming all-trans retinyl ester. Second RPE65, a very abundant RPE-specific protein that has been recently demonstrated to endow the isomerohydrolase activity, triggers the conversion of all-trans retinyl ester to 11-cis retinol. The lack of this essential enzyme is responsible for early onset forms of retinal dystrophies such as Leber congenital amaurosis, and childhood early onset retinal dystrophies (Marlhens et al., 1997; Gu et al., 1997). At last, 11-cis retinal is formed by 11-cis RDH and goes back to the photoreceptors to regenerate visual pigments.
 

The visual cycle in vertebrate

 

Methodologies

Initial two-hybrid approach

In order to identify novel RPE genes and to enlighten the regulation mechanisms of the visual cycle and RPE65-dependent isomerization step, we have investigated RPE65-interacting proteins through a yeast two-hybrid approach using full-length human RPE65 as a bait. Our screening has revealed 12 positive interactions with RPE65 in yeast among the 1.2x106 clones tested from a porcine RPE mRNA library.


Among them, we found:
- energetic metabolism proteins
- scaffolding proteins
- hypothetical proteins
- background proteins



Molecular and cellular biology

We apply tools and technologies developed for the exploration of the specificity, dynamic and functional impact of the protein interactions:

  1. cDNA collection encoding the main isomerisation partners (RPE65, LRAT, RDH5, CRALBP) and some of the newly discovered interacting proteins
  2. Recombinant protein production systems (in vitro translation, bacteria, yeast, insect cells, human cell lines) in collaboration with the recombinant protein production platform directed by Y. Boublik (UFR122, CNRS, CRBM UMR 5237, Montpellier).

           These cellular systems will allow us to describe the localization of the various partners (fluorescence confocal microscopy, Hassan Boukhaddaoui and the staff of the Montpellier RIO Imaging, MRI, facility), to measure their own activity and the effects of the substrates and products of all enzymatic partners (retinoid dosage, fatty acid uptake, glycolysis) and to study the role of the folding proteins in the recruitment of RPE65 to the membranes (subcellular fragmentation, immunocytochemistry).

 

Biochemistry of the visual cycle

In order to identify modulators of the visual cycle in the RPE, Laurent Guillou is using analytic HPLC to follow the conversion of vitamin A (all-trans retinol) into 11-cis retinol and to dose the various retinoid species. We apply this technique in vitro onto porcine RPE microsomes and Sf9 insect cells over-expressing the recombinant human proteins, and in vivo onto the mouse RPE.

 

Animal models

Behavioural and pathophysiological studies in normal and deficient animal

The physiological impact of the interacting proteins with a known function will be evaluated on normal and genetically modified mouse models (knockout or transgenic), either available or to be developed (double-knockout).

Innovating methodology to developped animal models

In the team, G. Lenaers group developed a novel approach of injection of small interfering RNA (siRNA) directly in the vitreous of young mice (post-natal day 11: P11, Chen-Kuo-Chang M., Abstract #3119, ARVO 2005) and in adults (Depeyre C., Chen-Kuo-Chang M. and Arndt C., J Fr Ophtalmol. 2006 29(8):875-80). The histochemical and functional validation of this approach at the two stages of development will provide a very interesting and novel tool to explore the function of RPE genes.


The Drosophila model

As in vertebrates, vitamin A derivatives serve as the visual chromophores in Drosophila. A β,β-carotene-15,15’-oxygenase (BCO) catalyzes the conversion of β-carotene to vitamin A. Only one BCO family member encoded by the ninaB gene is found in the entire Drosophila genome. The high degree of overall sequence identity (40%) shared by RPE65 and BCO in vertebrates points to a related biochemical function and the existence of a common ancestor. However,the RPE65 function does not include β-carotene cleaving activity. The protein required for the conversion of vitamin A to chromophore in Drosophila retinal pigment cells has still to be identified.

 

Phylogenetic tree calculation of BCO

 

 

Genetic

The genes encoding the interacting proteins are potential candidates for the mutation screening in patients with retinal dystrophies.

 

Two truncating RPE65 mutations in individuals with Leber congenital amaurosis. Fundus examination of patients 2 and 3, aged 20 years and 13 years, respectively, showed numerous yellowish spots in the outer layers of the retina.

From Marlhens F et al. (1997). Mutations in RPE65 cause Leber's congenital amaurosis.

Nat Genet. 1997;17(2):139-41.

 

References

Rando RR. The biochemistry of the visual cycle. Chem Rev. 2001; 101(7):1881-96.

Thompson DA, Gal A. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog Retin Eye Res. 2003;22(5):683-703.

Redmond TM, Yu S, Lee E, Bok D, Hamasaki D, Chen N, Goletz P, Ma JX, Crouch RK, Pfeifer K. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998; 20(4):344-51.

M. Jin, S. Li, W. Moghrabi, H. Sun, G. Travis. Rpe65 Is the Retinoid Isomerase in Bovine Retinal Pigment Epithelium. Cell 2005; Volume 122, Issue 3, Pages 449-459.

Moiseyev G, Takahashi Y, Chen Y, Gentleman S, Redmond TM, Crouch RK, Ma JX. RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle. J Biol Chem. 2006; 281(5):2835-40.

Guignard T, Pequignot MO, Ayoub B, Weber A, Ripoll C, Hamel C, Brabet P. Energetic metabolism proteins interact with RPE65 in vitro. ABSTRACT # 2030 - ARVO 2006

P. Brabet, Y. Chassigneux, T. Guignard, and C. Hamel. Search for new partners of RPE65 in retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2004 45: E-Abstract 1257.


Lab members


 

Haut de la page

L'institut | Domaines de recherche | Plates-formes techniques |
Venir à l'INM. Pourquoi? | Actu / Presse | Contact |
Accueil | Site map |  Légal & crédits
Directeur de publication: Christian Hamel
Copyright © INM 2006